{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:12:01Z","timestamp":1793391121528,"version":"4.5.0"},"reference-count":544,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["2026 AHA\/ACC\/ACCP\/ACEP\/CHEST\/SCAI\/SHM\/SIR\/SVM\/SVN"],"award-info":[{"award-number":["2026 AHA\/ACC\/ACCP\/ACEP\/CHEST\/SCAI\/SHM\/SIR\/SVM\/SVN"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","award":["1626\\u20131710"],"award-info":[{"award-number":["1626\\u20131710"]}],"id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","award":["212-633-3820"],"award-info":[{"award-number":["212-633-3820"]}],"id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009321","name":"American College of Emergency Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032803","name":"Society for Cardiovascular Angiography and Interventions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013607","name":"American College of Clinical Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jacc.2025.11.005","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T20:07:27Z","timestamp":1771531647000},"page":"1626-1710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["2026 AHA\/ACC\/ACCP\/ACEP\/CHEST\/SCAI\/SHM\/SIR\/SVM\/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults"],"prefix":"10.1016","volume":"87","author":[{"given":"Mark A.","family":"Creager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Schuyler","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison E.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Carman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Casanegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana A.","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrell M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Eaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Henkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary","family":"Johnston-Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabeeda","family":"Kadavath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Kadian-Dodov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Brent","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"McDaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Moores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Prenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Ranade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.","family":"Rosovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farla","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Secemsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh K.","family":"Sista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leben","family":"Tefera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Westafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.11.005_bib1","article-title":"2025 AHA\/ACC statement on cost\/value methodology in clinical practice guidelines (update from 2014 statement): a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","author":"Kazi","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib2","article-title":"2025 ACC\/AHA guideline core principles and development process: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","author":"Otto","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib3","article-title":"Guidance for incorporating FDA processes into the ACC\/AHA clinical practice guideline methodology: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","author":"Jneid","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib4","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib5","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib6","doi-asserted-by":"crossref","first-page":"e774","DOI":"10.1161\/CIR.0000000000000707","article-title":"Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association","volume":"140","author":"Giri","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"Kumbhani","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib8","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1161\/CIR.0000000000001117","article-title":"Surgical management and mechanical circulatory support in high-risk pulmonary embolisms: historical context, current status, and future directions: a scientific statement from the American Heart Association","volume":"147","author":"Goldberg","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib9","doi-asserted-by":"crossref","first-page":"e1090","DOI":"10.1161\/CIR.0000000000001197","article-title":"Status and future directions for balloon pulmonary angioplasty in chronic thromboembolic pulmonary disease with and without pulmonary hypertension: a scientific statement from the American Heart Association","volume":"149","author":"Aggarwal","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.295.2.172","article-title":"Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography","volume":"295","author":"van Belle","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/M21-2625","article-title":"Safety and efficiency of diagnostic strategies for ruling out pulmonary embolism in clinically relevant patient subgroups a systematic review and individual-patient data meta-analysis","volume":"175","author":"Stals","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib12","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1001\/jama.2021.20750","article-title":"Effect of a diagnostic strategy using an elevated and age-adjusted D-dimer threshold on thromboembolic events in emergency department patients with suspected pulmonary embolism: a randomized clinical trial","volume":"326","author":"Freund","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.2014.2135","article-title":"Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study","volume":"311","author":"Righini","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/jth.13630","article-title":"The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis","volume":"15","author":"van Es","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib15","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1056\/NEJMoa1909159","article-title":"Diagnosis of pulmonary embolism with d-Dimer adjusted to clinical probability","volume":"381","author":"Kearon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.annemergmed.2022.09.014","article-title":"Comparison of YEARS and adjust-unlikely D-dimer testing for pulmonary embolism in the emergency department","volume":"81","author":"de Wit","year":"2023","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jtha.2022.11.025","article-title":"Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data","volume":"21","author":"Stals","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib18","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/jth.15432","article-title":"D-Dimer to rule out venous thromboembolism during pregnancy: a systematic review and meta-analysis","volume":"19","author":"Bellesini","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa1813865","article-title":"Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism","volume":"380","author":"van der Pol","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMcp2116489","article-title":"Pulmonary embolism","volume":"387","author":"Kahn","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jacc.2010.05.071","article-title":"Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry)","volume":"57","author":"Pollack","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169268","article-title":"D-dimer use and pulmonary embolism diagnosis in emergency units: why is there such a difference in pulmonary embolism prevalence between the United States of America and countries outside USA?","volume":"12","author":"Pernod","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.11.005_bib23","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1001\/jama.2021.20750","article-title":"Effect of a diagnostic strategy using an elevated and age-adjusted D-dimer threshold on thromboembolic events in emergency department patients with suspected pulmonary embolism: a randomized clinical trial","volume":"326","author":"Freund","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MEJ.0000000000000680","article-title":"Investigation of pulmonary embolism in patients with chest pain in the emergency department: a retrospective multicenter study","volume":"27","author":"Lefevre-Scelles","year":"2020","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/acem.12221","article-title":"US trends in computed tomography use and diagnoses in emergency department visits by patients with symptoms suggestive of pulmonary embolism, 2001-2009","volume":"20","author":"Feng","year":"2013","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib26","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/jth.13694","article-title":"Diagnosis of acute pulmonary embolism","volume":"15","author":"Righini","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.amjmed.2019.01.011","article-title":"Pearls and myths in the evaluation of patients with suspected acute pulmonary embolism","volume":"132","author":"St\u00fcssi-Helbling","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib28","article-title":"Pulmonary embolism: update on management and controversies","volume":"370","author":"Duffett","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.11.005_bib29","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/jth.13654","article-title":"Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH","volume":"15","author":"Dronkers","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1538-7836.2008.02944.x","article-title":"Prospective multicenter evaluation of the pulmonary embolism rule-out criteria","volume":"6","author":"Kline","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(08)60594-2","article-title":"Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial","volume":"371","author":"Righini","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.11.005_bib32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1055\/s-0043-1764231","article-title":"Sex-related differences in patient characteristics, risk factors, and symptomatology in older adults with pulmonary embolism: findings from the SERIOUS-PE study","volume":"49","author":"Bikdeli","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib33","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1161\/CIRCULATIONAHA.120.052780","article-title":"Impact of the age-adjusted D-dimer cutoff to exclude pulmonary embolism: a multinational prospective real-life study (the RELAX-PE Study)","volume":"143","author":"Robert-Ebadi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(17)30885-1","article-title":"Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study","volume":"390","author":"van der Hulle","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.11.005_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jacr.2023.08.045","article-title":"Ten-year trend in advanced imaging utilization for suspected pulmonary embolism in pregnancy","volume":"21","author":"Goyal","year":"2024","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib36","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/acem.12471","article-title":"Systematic review and meta-analysis of pregnant patients investigated for suspected pulmonary embolism in the emergency department","volume":"21","author":"Kline","year":"2014","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-0037-1613830","article-title":"Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer","volume":"83","author":"Wells","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-144-3-200602070-00004","article-title":"Prediction of pulmonary embolism in the emergency department: the revised Geneva score","volume":"144","author":"Le Gal","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib39","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/archinte.168.19.2131","article-title":"Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism","volume":"168","author":"Klok","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/CIRCIMAGING.113.001080","article-title":"Multicenter, randomized trial of quantitative pretest probability to reduce unnecessary medical radiation exposure in emergency department patients with chest pain and dyspnea","volume":"7","author":"Kline","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.11.005_bib41","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa052367","article-title":"Multidetector computed tomography for acute pulmonary embolism","volume":"354","author":"Stein","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib42","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.298.23.2743","article-title":"Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial","volume":"298","author":"Anderson","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.295.2.172","article-title":"Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography","volume":"295","author":"van Belle","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib44","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(08)60594-2","article-title":"Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial","volume":"371","author":"Righini","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.11.005_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/jth.13188","article-title":"Multidetector computed tomographic pulmonary angiography in patients with a high clinical probability of pulmonary embolism","volume":"14","author":"Moores","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib46","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1160\/TH17-02-0076","article-title":"Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis","volume":"117","author":"van der Hulle","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib47","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00006231-200211000-00011","article-title":"Is a lung perfusion scan obtained by using single photon emission computed tomography able to improve the radionuclide diagnosis of pulmonary embolism?","volume":"23","author":"Collart","year":"2002","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jacc.2025.11.005_bib48","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.298.23.2743","article-title":"Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial","volume":"298","author":"Anderson","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib49","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.ejrad.2015.03.013","article-title":"Planar and SPECT ventilation\/perfusion imaging and computed tomography for the diagnosis of pulmonary embolism: a systematic review and meta-analysis of the literature, and cost and dose comparison","volume":"84","author":"Phillips","year":"2015","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib50","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1148\/radiol.2463070270","article-title":"Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study","volume":"246","author":"Sostman","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.jacc.2025.11.005_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075712","volume":"14","author":"Le Pennec","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2025.11.005_bib52","article-title":"Imaging for the exclusion of pulmonary embolism in pregnancy","volume":"1","author":"van Mens","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.11.005_bib53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.chest.2017.08.005","article-title":"Performance of low-dose perfusion scintigraphy and CT pulmonary angiography for pulmonary embolism in pregnancy","volume":"153","author":"Sheen","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib54","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-152-7-201004060-00008","article-title":"Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III)","volume":"152","author":"Stein","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib55","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1538-7836.2012.04652.x","article-title":"Diagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: results of the 'IRM-EP' study","volume":"10","author":"Revel","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib56","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ejrad.2015.12.018","article-title":"Contrast enhanced pulmonary magnetic resonance angiography for pulmonary embolism: building a successful program","volume":"85","author":"Nagle","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10140-018-1609-8","article-title":"Clinical outcomes after magnetic resonance angiography (MRA) versus computed tomographic angiography (CTA) for pulmonary embolism evaluation","volume":"25","author":"Repplinger","year":"2018","journal-title":"Emerg Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib58","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ejrad.2016.05.008","article-title":"Incidence of actionable findings on contrast enhanced magnetic resonance angiography ordered for pulmonary embolism evaluation","volume":"85","author":"Schiebler","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib59","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1378\/chest.15-0808","article-title":"Risk stratification of patients with acute symptomatic pulmonary embolism based on presence or absence of lower extremity DVT: systematic review and meta-analysis","volume":"149","author":"Becattini","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib60","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/rccm.200908-1204OC","article-title":"Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism","volume":"181","author":"Jimenez","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2022.11.007","article-title":"Deep vein thrombosis symptoms and 30-day mortality in acute pulmonary embolism","volume":"108","author":"Dubois-Silva","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib62","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1111\/j.1538-7836.2011.04533.x","article-title":"Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence","volume":"9","author":"Hamadah","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib63","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/CIRCULATIONAHA.118.037425","article-title":"Endovascular thrombus removal for acute iliofemoral deep vein thrombosis","volume":"139","author":"Comerota","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib64","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1538-7836.2008.03264.x","article-title":"Complete venous ultrasound in outpatients with suspected pulmonary embolism","volume":"7","author":"Righini","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2018.02.140","article-title":"Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism","volume":"164","author":"Quezada","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib66","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jemermed.2005.05.010","article-title":"Use of spiral computed tomography contrast angiography and ultrasonography to exclude the diagnosis of pulmonary embolism in the emergency department","volume":"29","author":"Anderson","year":"2005","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib67","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1160\/TH17-02-0076","article-title":"Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis","volume":"117","author":"Van Der Hulle","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib68","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.clinimag.2014.04.003","article-title":"Three-year clinical experience with VQ SPECT for diagnosing pulmonary embolism: diagnostic performance","volume":"38","author":"Gruning","year":"2014","journal-title":"Clin Imaging"},{"key":"10.1016\/j.jacc.2025.11.005_bib69","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.echo.2017.03.004","article-title":"Transthoracic echocardiography for diagnosing pulmonary embolism: a systematic review and meta-analysis","volume":"30","author":"Fields","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2025.11.005_bib70","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1161\/01.CIR.101.24.2817","article-title":"Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction","volume":"101","author":"Grifoni","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10140-007-0654-5","article-title":"CT venography vs ultrasound in the diagnosis of thromboembolic disease in patients with clinical suspicion of pulmonary embolism","volume":"14","author":"Garcia-Bolado","year":"2007","journal-title":"Emerg Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib72","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehr108","article-title":"Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test","volume":"32","author":"Becattini","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib73","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2214\/AJR.11.7439","article-title":"Axial and reformatted four-chamber right ventricle-to-left ventricle diameter ratios on pulmonary CT angiography as predictors of death after acute pulmonary embolism","volume":"198","author":"Lu","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacc.2025.11.005_bib74","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1183\/09031936.00147813","article-title":"Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis","volume":"43","author":"Becattini","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib75","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.thromres.2023.01.019","article-title":"Comparison of various prognostic scores for identification of patients with intermediate-high risk pulmonary embolism","volume":"223","author":"Mirambeaux","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib76","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib77","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1164\/rccm.200906-0970OC","article-title":"Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study","volume":"181","author":"Sanchez","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib78","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/acem.13774","article-title":"Increased sensitivity of focused cardiac ultrasound for pulmonary embolism in emergency department patients with abnormal vital signs","volume":"26","author":"Daley","year":"2019","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib79","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajem.2016.10.018","article-title":"Emergency physician performed tricuspid annular plane systolic excursion in the evaluation of suspected pulmonary embolism","volume":"35","author":"Daley","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib80","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.annemergmed.2016.01.027","article-title":"Diagnostic Accuracy of Right Ventricular Dysfunction Markers in Normotensive Emergency Department Patients With Acute Pulmonary Embolism","volume":"68","author":"Weekes","year":"2016","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib81","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jth.12589","article-title":"Prognostic significance of tricuspid annular displacement in normotensive patients with acute symptomatic pulmonary embolism","volume":"12","author":"Lobo","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib82","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1097\/CCM.0000000000002723","article-title":"Diagnostic accuracy of point-of-care ultrasound performed by pulmonary critical care physicians for right ventricle assessment in patients with acute pulmonary embolism","volume":"45","author":"Filopei","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib83","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.echo.2025.01.006","article-title":"Guidelines for the Echocardiographic Assessment of the right heart in adults and special considerations in pulmonary hypertension: recommendations from the American Society of Echocardiography","volume":"38","author":"Mukherjee","year":"2025","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2025.11.005_bib84","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018075","article-title":"Abnormal pulmonary venous filling: an adjunct feature in the computed tomography pulmonary angiogram assessment of chronic thromboembolic pulmonary hypertension","volume":"9","author":"Gopalan","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.11.005_bib85","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.healun.2019.03.003","article-title":"Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study","volume":"38","author":"Ende-Verhaar","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2025.11.005_bib86","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1007\/s00330-022-08804-5","article-title":"The diagnostic performance of CT pulmonary angiography in the detection of chronic thromboembolic pulmonary hypertension-systematic review and meta-analysis","volume":"32","author":"Lambert","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib87","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.chest.2022.11.045","article-title":"Preexisting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism","volume":"163","author":"Barco","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib89","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1007\/s00330-024-10593-y","article-title":"Validating the safety of low-dose CTPA in pregnancy: results from the OPTICA (Optimised CT Pulmonary Angiography in Pregnancy) study","volume":"34","author":"Gillespie","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib90","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s00392-022-02138-4","article-title":"Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2","volume":"112","author":"Mavromanoli","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib91","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib92","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/eurheartj\/ehz726","article-title":"The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism","volume":"40","author":"Konstantinides","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib93","article-title":"SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies","volume":"1","author":"Naidu","year":"2022","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib94","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/acem.14108","article-title":"Outpatient treatment of low-risk pulmonary embolism in the era of direct oral anticoagulants: a systematic review","volume":"28","author":"Maughan","year":"2021","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib95","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/eurheartj\/ehab373","article-title":"Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial","volume":"42","author":"Roy","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib96","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/eurheartj\/ehz367","article-title":"Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial","volume":"41","author":"Barco","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib97","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00412-2021","article-title":"Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism","volume":"59","author":"Jimenez","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib98","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s11739-022-02963-5","article-title":"Comparison of two scores in predicting pulmonary embolism-related adverse events in intermediate-high-risk patients: a systematic review and meta-analysis","volume":"17","author":"Bova","year":"2022","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.thromres.2022.03.005","article-title":"Performance of the Bova score in predicting short-term all-cause mortality in patients with pulmonary embolism and normal blood pressure. A systematic review and meta-analysis","volume":"213","author":"Bova","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.thromres.2023.01.019","article-title":"Comparison of various prognostic scores for identification of patients with intermediate-high risk pulmonary embolism","volume":"223","author":"Mirambeaux","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib101","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.10779","article-title":"Comparison of 4 acute pulmonary embolism mortality risk scores in patients evaluated by pulmonary embolism response teams","volume":"3","author":"Barnes","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.11.005_bib102","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.arbres.2022.11.016","article-title":"Usefulness of the National Early Warning Score for risk stratification of stable patients with acute symptomatic pulmonary embolism","volume":"59","author":"Rodr\u00edguez","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.jacc.2025.11.005_bib103","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1055\/s-0043-1769938","article-title":"National Early Warning Score-2 for identification of patients with intermediate-high-risk pulmonary embolism","volume":"49","author":"Rodr\u00edguez","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib104","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/emermed-2021-211506","article-title":"Use of the National Early Warning Score for predicting deterioration of patients with acute pulmonary embolism: a post-hoc analysis of the YEARS Study","volume":"40","author":"Bavalia","year":"2023","journal-title":"Emerg Med J"},{"key":"10.1016\/j.jacc.2025.11.005_bib105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/jcdd10020060","article-title":"Predictive ability of the National Early Warning Score in mortality prediction of acute pulmonary embolism in the southeast Asian population","volume":"10","author":"Bumroongkit","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.jacc.2025.11.005_bib106","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010324","article-title":"Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis","volume":"6","author":"Elias","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2025.11.005_bib107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2022.05.011","article-title":"Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: rationale and design of the HI-PEITHO study","volume":"251","author":"Klok","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib108","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221126173","article-title":"Prognostic performance of Hestia criteria in acute pulmonary embolism: a systematic review and meta-analysis","volume":"28","author":"Wang","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib109","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.thromres.2023.11.011","article-title":"Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism","volume":"233","author":"Najarro","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib110","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00392-019-01593-w","article-title":"Validation of a fast prognostic score for risk stratification of normotensive patients with acute pulmonary embolism","volume":"109","author":"Hobohm","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib111","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jcin.2023.02.004","article-title":"Prevalence and predictors of cardiogenic shock in intermediate-risk pulmonary embolism: insights from the FLASH Registry","volume":"16","author":"Bangalore","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib112","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.medcli.2021.04.035","article-title":"In-hospital mortality of acute pulmonary embolism: predictive value of shock index, modified shock index, and age shock index scores","volume":"158","author":"Gokcek","year":"2022","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jacc.2025.11.005_bib113","doi-asserted-by":"crossref","first-page":"282","DOI":"10.14744\/AnatolJCardiol.2023.2530","article-title":"A new index for the prediction of in-hospital mortality in patients with acute pulmonary embolism: the Modified Shock Index","volume":"27","author":"Turkday Derebey","year":"2023","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib114","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2022.05.011","article-title":"Ultrasound-facilitated, catheter-directed thrombolysis versus anticoagulation alone for acute intermediate-high-risk pulmonary embolism: rationale and design of the HI-PEITHO study","volume":"251","author":"Klok","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib115","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jcin.2023.02.004","article-title":"Prevalence and predictors of cardiogenic shock in intermediate-risk pulmonary embolism: insights from the FLASH Registry","volume":"16","author":"Bangalore","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib116","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib117","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.thromres.2012.05.032","article-title":"Rapid improvement of renal function in patients with acute pulmonary embolism indicates favorable short term prognosis","volume":"130","author":"Kostrubiec","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib118","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11239-022-02633-5","article-title":"Prognostic impact of acute kidney injury in patients with acute pulmonary embolism data from the RIETE registry","volume":"54","author":"Murgier","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib119","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007678","article-title":"Defining shock and preshock for mortality risk stratification in cardiac intensive care unit patients","volume":"14","author":"Jentzer","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.11.005_bib120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031427","article-title":"Noninvasive hemodynamic characterization of shock and preshock using echocardiography in cardiac intensive care unit patients","volume":"12","author":"Jentzer","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.11.005_bib121","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-9343(00)00310-7","article-title":"Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry","volume":"108","author":"Menon","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib122","first-page":"80","article-title":"Mean arterial pressure predicts 48 h clinical deterioration in intermediate-high risk patients with acute pulmonary embolism","volume":"12","author":"Zuin","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacc.2025.11.005_bib123","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620933944","article-title":"Optimal mean arterial pressure within 24 hours of admission for patients with intermediate-risk and high-risk pulmonary embolism","volume":"26","author":"Chen","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib124","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.thromres.2023.11.011","article-title":"Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism","volume":"233","author":"Najarro","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1378\/chest.14-2551","article-title":"Validation of a model for identification of patients at intermediate to high risk for complications associated with acute symptomatic pulmonary embolism","volume":"148","author":"Fern\u00e1ndez","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rmed.2019.08.011","article-title":"Elevated serum cardiac troponin and mortality in acute pulmonary embolism: systematic review and meta-analysis","volume":"157","author":"El-Menyar","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib127","first-page":"423","article-title":"Importance of troponin T for the risk stratification of normotensive patients with pulmonary embolism. A prospective, cohort study with a three-month follow-up","volume":"90","author":"Bova","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jacc.2025.11.005_bib128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.106.680421","article-title":"Prognostic value of troponins in acute pulmonary embolism: a meta-analysis","volume":"116","author":"Becattini","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib129","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1183\/09031936.00174514","article-title":"Age-adjusted high-sensitivity troponin T cut-off value for risk stratification of pulmonary embolism","volume":"45","author":"Kaeberich","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib130","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/CIRCULATIONAHA.111.051177","article-title":"Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study","volume":"124","author":"Lankeit","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib131","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/eurheartj\/ehq234","article-title":"Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism","volume":"31","author":"Lankeit","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102437","article-title":"The significance of B-type natriuretic peptide in predicting early mortality among pulmonary embolism patients, alongside troponin: insights from a multicentric registry","volume":"49","author":"Boris","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib133","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/MEJ.0b013e3280bef891","article-title":"Comparison of troponin I and N-terminal-pro B-type natriuretic peptide for risk stratification in patients with pulmonary embolism","volume":"14","author":"Maziere","year":"2007","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib134","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.105.552216","article-title":"N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism","volume":"112","author":"Binder","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib135","doi-asserted-by":"crossref","DOI":"10.1186\/cc6996","article-title":"Prognostic value of brain natriuretic peptide in acute pulmonary embolism","volume":"12","author":"Coutance","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.jacc.2025.11.005_bib136","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2478\/rjc-2022-0034","article-title":"Serum lactate, an independent prognostic marker in normotensive patients with acute pulmonary thromboembolism","volume":"32","author":"Avram","year":"2022","journal-title":"Romanian Journal of Cardiology"},{"key":"10.1016\/j.jacc.2025.11.005_bib137","doi-asserted-by":"crossref","first-page":"ehaa946","DOI":"10.1093\/ehjci\/ehaa946.2275","article-title":"Serum lactate levels are an independent marker for complications in acute pulmonary embolism: from the PERT registry","volume":"41","author":"Wasserstrum","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib138","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/02683555221081818","article-title":"Prognostic role of elevated lactate in acute pulmonary embolism: a systematic review and meta-analysis","volume":"37","author":"Wang","year":"2022","journal-title":"Phlebology"},{"key":"10.1016\/j.jacc.2025.11.005_bib139","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2021.01.021","article-title":"Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism","volume":"86","author":"Ebner","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.thromres.2017.05.030","article-title":"Different time course of plasma lactate, troponin I and Nt-proBNP concentrations in patients with acute pulmonary embolism","volume":"156","author":"Liedl","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib141","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.annemergmed.2012.10.022","article-title":"Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: the thrombo-embolism lactate outcome study","volume":"61","author":"Vanni","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib142","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1553-2712.2011.01128.x","article-title":"High plasma lactate levels are associated with increased risk of in-hospital mortality in patients with pulmonary embolism","volume":"18","author":"Vanni","year":"2011","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib143","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1055\/s-0044-1786820","article-title":"Optimizing use of high-sensitivity troponin for risk-stratification of acute pulmonary embolism","volume":"124","author":"Goraya","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib144","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib145","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/acem.14484","article-title":"Can right ventricular assessments improve triaging of low risk pulmonary embolism?","volume":"29","author":"Raper","year":"2022","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib146","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/eurheartj\/ehy873","article-title":"Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis","volume":"40","author":"Barco","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib147","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/eurheartj\/ehab329","article-title":"Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis","volume":"42","author":"Becattini","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib148","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.arbr.2020.03.006","article-title":"Need for transthoracic echocardiogram in patients with low-risk pulmonary thromboembolism: a systematic review and meta-analysis","volume":"56","author":"Andrade","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.jacc.2025.11.005_bib149","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/acem.13108","article-title":"Assessment of right ventricular strain by computed tomography versus echocardiography in acute pulmonary embolism","volume":"24","author":"Dudzinski","year":"2017","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjmed.2015.01.023","article-title":"Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta-analysis","volume":"128","author":"Meinel","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276202","article-title":"Diagnostic accuracy of multiorgan point-of-care ultrasound compared with pulmonary computed tomographic angiogram in critically ill patients with suspected pulmonary embolism","volume":"17","author":"Girardi","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.11.005_bib152","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009042","article-title":"Early use of echocardiography in patients with acute pulmonary embolism: findings from the RIETE Registry","volume":"7","author":"Bikdeli","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.11.005_bib153","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0120-2022","article-title":"Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis","volume":"31","author":"Prosperi-Porta","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jacc.2025.11.005_bib154","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1111\/jth.15453","article-title":"Detection of right ventricular dysfunction in acute pulmonary embolism by computed tomography or echocardiography: a systematic review and meta-analysis","volume":"19","author":"Chornenki","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib155","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/jth.12429","article-title":"Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis","volume":"11","author":"Vedovati","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib156","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.amjcard.2016.08.025","article-title":"Relation among clot burden, right-sided heart strain, and adverse events after acute pulmonary embolism","volume":"118","author":"Hariharan","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib157","doi-asserted-by":"crossref","DOI":"10.1177\/20584601231187094","article-title":"Does the clot burden as assessed by the Mean Bilateral Proximal Extension of the Clot score reflect mortality and adverse outcome after pulmonary embolism?","volume":"12","author":"Gleditsch","year":"2023","journal-title":"Acta Radiologica Open"},{"key":"10.1016\/j.jacc.2025.11.005_bib158","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.012347","article-title":"Loss of pulmonary vascular volume as a predictor of right ventricular dysfunction and mortality in acute pulmonary embolism","volume":"14","author":"Minhas","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.11.005_bib159","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/eurheartj\/ehab373","article-title":"Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial","volume":"42","author":"Roy","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib160","article-title":"Outpatient versus inpatient treatment for acute pulmonary embolism","volume":"5","author":"Yoo","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.11.005_bib161","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1111\/j.1538-7836.2010.04041.x","article-title":"Safety of outpatient treatment in acute pulmonary embolism","volume":"8","author":"Erkens","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib162","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/acem.14181","article-title":"Outpatient management of patients following diagnosis of acute pulmonary embolism","volume":"28","author":"Westafer","year":"2021","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib163","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02368-2020","article-title":"Survival and quality of life after early discharge in low-risk pulmonary embolism","volume":"57","author":"Barco","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib164","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/acem.13451","article-title":"Emergency department discharge of pulmonary embolus patients","volume":"25","author":"Frank Peacock","year":"2018","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib165","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/rccm.201512-2494OC","article-title":"Efficacy and safety of outpatient treatment based on the Hestia Clinical Decision Rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism. A randomized clinical trial","volume":"194","author":"den Exter","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib166","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/PPA.S104446","article-title":"Outpatient treatment of low-risk venous thromboembolism with monotherapy oral anticoagulation: patient quality of life outcomes and clinician acceptance","volume":"10","author":"Kline","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jacc.2025.11.005_bib167","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2011.04388.x","article-title":"Outpatient treatment in patients with acute pulmonary embolism: the Hestia study","volume":"9","author":"Zondag","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib168","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(11)60824-6","article-title":"Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial","volume":"378","author":"Aujesky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.11.005_bib169","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chest.2018.01.035","article-title":"Management of low-risk pulmonary embolism patients without hospitalization: the Low-Risk Pulmonary Embolism Prospective Management study","volume":"154","author":"Bledsoe","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib170","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2017.06.024","article-title":"Safety, feasibility and patient reported outcome measures of outpatient treatment of pulmonary embolism","volume":"156","author":"Walen","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib171","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/rccm.201512-2494OC","article-title":"Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial","volume":"194","author":"den Exter","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib172","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(11)60824-6","article-title":"Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial","volume":"378","author":"Aujesky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.11.005_bib173","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/acem.14108","article-title":"Outpatient treatment of low-risk pulmonary embolism in the era of direct oral anticoagulants: a systematic review","volume":"28","author":"Maughan","year":"2021","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib174","first-page":"2933","article-title":"Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis","volume":"45","author":"Luijten","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib175","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/CIRCULATIONAHA.124.072364","article-title":"Large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the management of intermediate-risk pulmonary embolism: primary results of the PEERLESS randomized controlled trial","volume":"151","author":"Jaber","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib176","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s13054-021-03679-2","article-title":"Advanced management of intermediate-high risk pulmonary embolism","volume":"25","author":"Weinstein","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jacc.2025.11.005_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajmo.2023.100053","article-title":"Trends and Outcomes of Interhospital Transfer for High-Risk Acute Pulmonary Embolism: A Nationwide Analysis","volume":"10","author":"Sedhom","year":"2023","journal-title":"Am J Med Open"},{"key":"10.1016\/j.jacc.2025.11.005_bib178","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib179","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.ccm.0000807728.22659.88","article-title":"We can't take them all: triage of pulmonary embolism transfer requests to a regional PERT center","volume":"50","author":"Downing","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11239-020-02188-3","article-title":"Value-based assessment of implementing a Pulmonary Embolism Response Team (PERT)","volume":"51","author":"Annabathula","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib181","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.thromres.2022.11.017","article-title":"Effect of pulmonary embolism response team on advanced therapies administered: the University of Michigan experience","volume":"221","author":"Ardeshna","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib182","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.3390\/jcm11206129","article-title":"Pulmonary embolism response teams: theory, implementation, and unanswered questions","volume":"11","author":"Bejjani","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib183","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.amjmed.2020.03.058","article-title":"Changes in care for acute pulmonary embolism through a multidisciplinary pulmonary embolism response team","volume":"133","author":"Carroll","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib184","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.amjcard.2019.07.043","article-title":"Impact of multidisciplinary pulmonary embolism response team availability on management and outcomes","volume":"124","author":"Chaudhury","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib185","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0023-2022","article-title":"Impact of pulmonary embolism response teams on acute pulmonary embolism: a systematic review and meta-analysis","volume":"31","author":"Fleitas Sosa","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jacc.2025.11.005_bib186","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12959-024-00605-8","article-title":"Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study","volume":"22","author":"Gardner","year":"2024","journal-title":"Thromb J"},{"key":"10.1016\/j.jacc.2025.11.005_bib187","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/jac5.1569","article-title":"Pharmacists as members of an interdisciplinary pulmonary embolism response team","volume":"5","author":"Groth","year":"2022","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1016\/j.jacc.2025.11.005_bib188","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.hlc.2019.02.190","article-title":"Assessing the impact of a pulmonary embolism response team and treatment protocol on patients presenting with acute pulmonary embolism","volume":"29","author":"Jen","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2025.11.005_bib189","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620928420","article-title":"Effects of a consensus-based pulmonary embolism treatment algorithm and response team on treatment modality choices, outcomes, and complications","volume":"26","author":"Melamed","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib190","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jvsv.2023.05.016","article-title":"Effect of a pulmonary embolism response team on the management and outcomes of patients with acute pulmonary embolism","volume":"11","author":"Russell","year":"2023","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jacc.2025.11.005_bib191","doi-asserted-by":"crossref","first-page":"e1808","DOI":"10.1093\/milmed\/usac318","article-title":"Standardization of pulmonary embolism evaluation and management through implementation of a pulmonary embolism response team: a single-center experience at Brooke Army Medical Center","volume":"188","author":"Tunzi","year":"2023","journal-title":"Mil Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib192","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jvsv.2019.12.077","article-title":"Evaluating time to treatment and in-hospital outcomes of pulmonary embolism response teams","volume":"8","author":"Wiske","year":"2020","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jacc.2025.11.005_bib193","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.amjcard.2021.08.066","article-title":"Effect of a multidisciplinary pulmonary embolism response team on patient mortality","volume":"161","author":"Wright","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib194","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jvsv.2018.11.014","article-title":"The implementation of a pulmonary embolism response team in the management of intermediate- or high-risk pulmonary embolism","volume":"7","author":"Xenos","year":"2019","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jacc.2025.11.005_bib195","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00392-022-02077-0","article-title":"Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis","volume":"112","author":"Hobohm","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib196","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/1358863X18767753","article-title":"The impact of a multi-specialty team for high risk pulmonary embolism on resident and fellow education","volume":"23","author":"Elbadawi","year":"2018","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib197","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ccm.2018.04.019","article-title":"Pulmonary embolism response team: inpatient structure, outpatient follow-up, and is it the current standard of care?","volume":"39","author":"Rosovsky","year":"2018","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib198","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(60)92299-6","article-title":"Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial","volume":"1","author":"Barritt","year":"1960","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jacc.2025.11.005_bib199","article-title":"Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism","volume":"2","author":"Robertson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.11.005_bib200","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","article-title":"Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis","volume":"377","author":"Vedantham","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib201","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2756682","article-title":"Effectiveness and safety of nonvitamin K oral anticoagulants rivaroxaban and apixaban in patients with venous thromboembolism: a meta-analysis of real-world studies","volume":"2022","author":"Wu","year":"2022","journal-title":"Cardiovascular Ther"},{"key":"10.1016\/j.jacc.2025.11.005_bib202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12872-023-03067-4","article-title":"Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis","volume":"23","author":"Park","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.11.005_bib203","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1060028020923584","article-title":"Direct oral anticoagulants in obesity: an updated literature review","volume":"54","author":"Sebaaly","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2025.11.005_bib204","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.thromres.2023.12.001","article-title":"Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism","volume":"233","author":"Rueda-Camino","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10557-020-07126-2","article-title":"Comparative effectiveness and safety of direct oral anticoagulants in obese patients with atrial fibrillation","volume":"35","author":"Briasoulis","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2025.11.005_bib206","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulant in the treatment of patients with morbid obesity or high body weight with venous thromboembolism: a meta-analysis","volume":"102","author":"Zhang","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2025.11.005_bib207","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11239-023-02774-1","article-title":"DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network","volume":"55","author":"Martin","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib208","article-title":"Strategies involving low-molecular-weight heparin for the treatment and prevention of venous thromboembolism in patients with obesity: a systematic review and meta-analysis","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jacc.2025.11.005_bib209","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1060028018821149","article-title":"Evaluation of treatment-dose enoxaparin in acutely ill morbidly obese patients at an academic medical center: a randomized clinical trial","volume":"53","author":"Curry","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2025.11.005_bib210","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001018","article-title":"Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials","volume":"10","author":"Adelhelm","year":"2023","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib211","article-title":"Efficacy and safety of direct oral anticoagulants in patients with antiphospholipid syndrome: a systematic review and meta-analysis","volume":"14","author":"Gullapalli","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jacc.2025.11.005_bib212","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1097\/MS9.0000000000000903","article-title":"Direct oral anticoagulants vs. vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis","volume":"85","author":"Shah","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.jacc.2025.11.005_bib213","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials","volume":"81","author":"Khairani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib214","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1182\/bloodadvances.2022008086","article-title":"ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis","volume":"6","author":"Giustozzi","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jacc.2025.11.005_bib215","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jtha.2023.10.011","article-title":"Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review","volume":"22","author":"Iyengar","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107243","article-title":"Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: a meta-analysis","volume":"32","author":"Yang","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jacc.2025.11.005_bib217","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.thromres.2020.11.036","article-title":"Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: a systematic review and meta-analysis","volume":"198","author":"Alhousani","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib218","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40261-021-01016-7","article-title":"Efficacy and safety of direct oral anticoagulants vs warfarin in patients with chronic kidney disease and dialysis patients: a systematic review and meta-analysis","volume":"41","author":"Chen","year":"2021","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jacc.2025.11.005_bib219","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s40620-022-01413-x","article-title":"A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease","volume":"35","author":"Parker","year":"2022","journal-title":"J Nephrol"},{"key":"10.1016\/j.jacc.2025.11.005_bib220","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jhm.12926","article-title":"Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end-stage kidney disease: a national cohort study","volume":"17","author":"Ellenbogen","year":"2022","journal-title":"J Hosp Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib221","article-title":"Safety and efficacy of apixaban vs warfarin in patients with stage 4 and 5 chronic kidney disease: a systematic review","volume":"14","author":"Fatima","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jacc.2025.11.005_bib222","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jth.12085","article-title":"Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature","volume":"11","author":"Romualdi","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib223","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1515\/jpm-2021-0457","article-title":"Experience with direct oral anticoagulants in pregnancy - a systematic review","volume":"50","author":"Areia","year":"2022","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib224","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0040-1710314","article-title":"Treatment of venous thromboembolism in special populations with direct oral anticoagulants","volume":"120","author":"Bavalia","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102293","article-title":"Venous thromboembolism, chronic liver disease and anticoagulant choice: effectiveness and safety of direct oral anticoagulants versus warfarin","volume":"8","author":"Lawal","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib226","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jvir.2019.12.003","article-title":"Safety of therapeutic anticoagulation with low-molecular-weight heparin or unfractionated heparin infusion during catheter-directed thrombolysis for acute pulmonary embolism","volume":"31","author":"Graif","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib227","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jama.2014.10538","article-title":"Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis","volume":"312","author":"Castellucci","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib228","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00408-014-9660-z","article-title":"Comparison of LMWH versus UFH for hemorrhage and hospital mortality in the treatment of acute massive pulmonary thromboembolism after thrombolytic treatment: randomized controlled parallel group study","volume":"193","author":"Ucar","year":"2015","journal-title":"Lung"},{"key":"10.1016\/j.jacc.2025.11.005_bib229","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1076029614564863","article-title":"Should low-molecular-weight heparin be preferred over unfractionated heparin after thrombolysis for severity pulmonary embolism?","volume":"22","author":"Senturk","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2025.11.005_bib230","first-page":"49","article-title":"Laboratory assays for the evaluation of recombinant hirudin","volume":"21","author":"Walenga","year":"1991","journal-title":"Haemostasis"},{"key":"10.1016\/j.jacc.2025.11.005_bib231","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2004.10.004","article-title":"Dosage of enoxaparin among obese and renal impairment patients","volume":"116","author":"Bazinet","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib232","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/0091270003253420","article-title":"Correlation of antifactor Xa concentrations with renal function in patients on enoxaparin","volume":"43","author":"Chow","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2025.11.005_bib233","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/imj.13117","article-title":"Evaluation of therapeutic enoxaparin in a pregnant population at a tertiary hospital","volume":"46","author":"Petrie","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/j.jacc.2025.11.005_bib234","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ajog.2004.05.050","article-title":"A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation","volume":"191","author":"Barbour","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.11.005_bib235","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/1076029614568713","article-title":"Evaluation and pharmacokinetics of treatment dose enoxaparin in hospitalized patients with morbid obesity","volume":"21","author":"Thompson-Moore","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib236","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jcph.2210","article-title":"Low early antifactor Xa target achievement rate of low-molecular-weight heparin for treating venous thromboembolism in patients in intensive care","volume":"63","author":"Zhang","year":"2023","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2025.11.005_bib237","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0140-6736(92)91054-C","article-title":"Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis","volume":"339","author":"Prandoni","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.11.005_bib238","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199603143341101","article-title":"A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis","volume":"334","author":"Levine","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib239","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM199709043371001","article-title":"Low-molecular-weight heparin in the treatment of patients with venous thromboembolism","volume":"337","author":"Columbus","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib240","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM199204093261502","article-title":"Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis","volume":"326","author":"Hull","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib241","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199603143341102","article-title":"Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group","volume":"334","author":"Koopman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib242","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1055\/s-0038-1642507","article-title":"Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group","volume":"71","author":"Alhenc-Gelas","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib243","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJM199205073261902","article-title":"The clinical course of pulmonary embolism","volume":"326","author":"Carson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib244","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2025.11.005_bib245","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2756682","article-title":"Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies","volume":"2022","author":"Wu","year":"2022","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jacc.2025.11.005_bib246","article-title":"Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism","volume":"4","author":"Li","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.11.005_bib247","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.2174\/1381612826666200506114450","article-title":"Non-vitamin K antagonist oral anticoagulants in pulmonary embolism: an overview of systematic reviews","volume":"26","author":"Doundoulakis","year":"2020","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jacc.2025.11.005_bib248","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/jth.13139","article-title":"Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Chai-Adisaksopha","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib249","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1074248415575154","article-title":"Case fatality rates of recurrent thromboembolism and bleeding in patients receiving direct oral anticoagulants for the initial and extended treatment of venous thromboembolism","volume":"20","author":"G\u00f3mez-Outes","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacc.2025.11.005_bib250","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2147\/PPA.S131157","article-title":"Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism","volume":"11","author":"Keita","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jacc.2025.11.005_bib251","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jth.15358","article-title":"Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Martin","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib252","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.amjmed.2023.01.010","article-title":"Direct oral anticoagulants in obese patients with venous thromboembolism: results of an expert consensus panel","volume":"136","author":"Rosovsky","year":"2023","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102240","article-title":"Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review","volume":"7","author":"Speed","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib254","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1016\/j.jtha.2024.08.009","article-title":"Treatment of atrial fibrillation and venous thromboembolism with factor Xa inhibitors in severely obese patients","volume":"22","author":"Dobry","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib255","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/s-0040-1718405","article-title":"Dosage of anticoagulants in obesity: recommendations based on a systematic review","volume":"46","author":"Abildgaard","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib256","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11239-024-02951-w","article-title":"A systematic review of therapeutic enoxaparin dosing in obesity","volume":"57","author":"Chilbert","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib257","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.medcli.2023.03.011","article-title":"Direct-acting oral anticoagulants in antiphospholipid syndrome: a systematic review","volume":"161","author":"Gir\u00f3n-Ortega","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jacc.2025.11.005_bib258","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/1060028020967635","article-title":"Direct oral anticoagulant use in chronic kidney disease and dialysis patients with venous thromboembolism: a systematic review of thrombosis and bleeding outcomes","volume":"55","author":"Cheung","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2025.11.005_bib259","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(65)90518-1","article-title":"Placental transport of heparin","volume":"93","author":"Flessa","year":"1965","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.11.005_bib260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11239-008-0207-0","article-title":"A descriptive evaluation of unfractionated heparin use during pregnancy","volume":"27","author":"Clark","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib261","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0049-3848(84)90260-3","article-title":"Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound","volume":"34","author":"Forestier","year":"1984","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib262","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.jacc.2025.11.005_bib263","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11239-019-01867-0","article-title":"Thrombolysis in hemodynamically unstable patients: still underused: a review based on multicenter prospective registries on acute pulmonary embolism","volume":"48","author":"Zuin","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib264","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0037-1612970","article-title":"Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin","volume":"87","author":"Pettila","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib265","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib266","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2016.06.076","article-title":"Anticoagulation during pregnancy: evolving strategies with a focus on mechanical valves","volume":"68","author":"Alshawabkeh","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib267","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.2020006231","article-title":"Are apixaban and rivaroxaban distributed into human breast milk to clinically relevant concentrations?","volume":"136","author":"Zhao","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2025.11.005_bib268","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/17843286.2022.2108259","article-title":"Safety of direct oral anticoagulants in patients with liver disease: a systematic review and meta-analysis","volume":"78","author":"Zhao","year":"2023","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.jacc.2025.11.005_bib269","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(02)07920-5","article-title":"Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors","volume":"359","author":"Dorffler-Melly","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.11.005_bib270","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/01.ta.0000197354.69796.bd","article-title":"Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients","volume":"59","author":"Haas","year":"2005","journal-title":"J Trauma"},{"key":"10.1016\/j.jacc.2025.11.005_bib271","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.jtha.2025.06.025","article-title":"A systematic review on anti-Xa monitoring in the therapeutic use of low-molecular-weight heparins","volume":"23","author":"Jaspers","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib272","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00003246-198512000-00004","article-title":"Dobutamine: a hemodynamic evaluation in pulmonary embolism shock","volume":"13","author":"Jardin","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib273","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib274","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib275","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib276","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00003246-199903000-00032","article-title":"Hemodynamic effects of fluid loading in acute massive pulmonary embolism","volume":"27","author":"Mercat","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib277","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12890-021-01440-7","article-title":"Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial","volume":"21","author":"Andersen","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib278","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.niox.2019.01.006","article-title":"Inhaled nitric oxide to treat intermediate risk pulmonary embolism: a multicenter randomized controlled trial","volume":"84","author":"Kline","year":"2019","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jacc.2025.11.005_bib279","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-10-18","article-title":"No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial","volume":"10","author":"Kooter","year":"2010","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib280","article-title":"Hemodynamic and respiratory support in pulmonary embolism: a narrative review","volume":"10","author":"P\u00e9rez-Nieto","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jacc.2025.11.005_bib281","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1074248414559838","article-title":"Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit","volume":"20","author":"Jentzer","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacc.2025.11.005_bib282","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ccc.2020.02.006","article-title":"Management of right ventricular failure in pulmonary embolism","volume":"36","author":"Zhao","year":"2020","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.jacc.2025.11.005_bib283","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.avsg.2019.12.008","article-title":"Predictive model for pulmonary embolism in patients with deep vein thrombosis","volume":"66","author":"Zhao","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib284","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ejhf.478","article-title":"Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology","volume":"18","author":"Harjola","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.11.005_bib285","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00000542-198402000-00009","article-title":"Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs","volume":"60","author":"Ghignone","year":"1984","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacc.2025.11.005_bib286","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.jvir.2019.08.009","article-title":"Sedation with propofol during catheter-directed thrombolysis for acute submassive pulmonary embolism is associated with increased mortality","volume":"30","author":"Manchec","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib287","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1213\/01.ane.0000208970.14762.7f","article-title":"Acute hemodynamic collapse after induction of general anesthesia for emergent pulmonary embolectomy","volume":"102","author":"Rosenberger","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2025.11.005_bib288","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.semtcvs.2021.06.011","article-title":"Comparison of surgical embolectomy and veno-arterial extracorporeal membrane oxygenation for massive pulmonary embolism","volume":"34","author":"Goldberg","year":"2022","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib289","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5578\/tt.20219604","article-title":"Comparison of the effectiveness of high-flow and conventional nasal cannula oxygen therapy in pulmonary embolism patients with acute hypoxemic respiratory failure","volume":"69","author":"Aksakal","year":"2021","journal-title":"Tuberkuloz ve Toraks"},{"key":"10.1016\/j.jacc.2025.11.005_bib290","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.chest.2023.09.007","article-title":"Oxygen therapy in patients with intermediate-risk acute pulmonary embolism: a randomized trial","volume":"165","author":"Barrios","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib291","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jama.2022.0028","article-title":"Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized clinical trial","volume":"327","author":"Perkins","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib292","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure","volume":"372","author":"Frat","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib293","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-020-06312-y","article-title":"The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline","volume":"46","author":"Rochwerg","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib294","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.201605-0916OC","article-title":"Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure","volume":"195","author":"Mauri","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib295","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01574-2021","article-title":"ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure","volume":"59","author":"Oczkowski","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib296","doi-asserted-by":"crossref","first-page":"463.e1","DOI":"10.1016\/j.ajem.2012.08.030","article-title":"High-flow oxygen, a therapeutic bridge while awaiting thrombolysis in pulmonary embolism?","volume":"31","author":"Lacroix","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib297","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.mjafi.2021.03.014","article-title":"Effectiveness of high flow nasal cannula oxygen therapy in patients of acute pulmonary thromboembolism with acute hypoxemic respiratory failure","volume":"78","author":"Marwah","year":"2022","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.jacc.2025.11.005_bib298","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MEJ.0000000000000420","article-title":"Severe pulmonary embolism managed with high-flow nasal cannula oxygen therapy","volume":"24","author":"Messika","year":"2017","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib299","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2022.10.138","article-title":"Anticoagulant management for transition from failed thrombolysis to extra-corporeal membrane oxygenation in patients with high-risk pulmonary embolism: a thoughtful approach","volume":"370","author":"Vandenbriele","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib300","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","article-title":"2021 ELSO adult and pediatric anticoagulation guidelines","volume":"68","author":"McMichael","year":"2022","journal-title":"ASAIO J"},{"key":"10.1016\/j.jacc.2025.11.005_bib301","article-title":"A meta-analysis comparing venoarterial (VA) extracorporeal membrane oxygenation (ECMO) to Impella for acute right ventricle failure","volume":"13","author":"Affas","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jacc.2025.11.005_bib302","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.athoracsur.2017.08.033","article-title":"Utilization of veno-arterial extracorporeal membrane oxygenation for massive pulmonary embolism","volume":"105","author":"Pasrija","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib303","doi-asserted-by":"crossref","DOI":"10.1016\/j.resuscitation.2023.109926","article-title":"Neurological outcomes and reperfusion strategies in out-of-hospital cardiac arrest patients due to pulmonary embolism who underwent venoarterial extracorporeal membrane oxygenation: a post-hoc analysis of a multicenter retrospective cohort study","volume":"191","author":"Sakuraya","year":"2023","journal-title":"Resuscitation"},{"key":"10.1016\/j.jacc.2025.11.005_bib304","doi-asserted-by":"crossref","DOI":"10.1016\/j.resuscitation.2023.109940","article-title":"Extracorporeal membrane oxygenation for the treatment of massive pulmonary embolism. An analysis of the ELSO database","volume":"191","author":"Rivers","year":"2023","journal-title":"Resuscitation"},{"key":"10.1016\/j.jacc.2025.11.005_bib305","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/CCM.0000000000004828","article-title":"Venoarterial extracorporeal membrane oxygenation in massive pulmonary embolism-related cardiac arrest: a systematic review","volume":"49","author":"Scott","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib306","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.semtcvs.2021.06.011","article-title":"Comparison of surgical embolectomy and veno-arterial extracorporeal membrane oxygenation for massive pulmonary embolism","volume":"34","author":"Goldberg","year":"2022","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib307","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1097\/CCM.0000000000006361","article-title":"Extracorporeal membrane oxygenation and reperfusion strategies in high-risk pulmonary embolism hospitalizations","volume":"52","author":"Farmakis","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib308","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study","volume":"112","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib309","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial","volume":"313","author":"Mismetti","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib310","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejvs.2013.06.007","article-title":"Technical and patient-related characteristics associated with challenging retrieval of inferior vena cava filters","volume":"46","author":"Avgerinos","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib311","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2017.07.775","article-title":"Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis","volume":"70","author":"Bikdeli","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib312","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.jacc.2014.01.058","article-title":"Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk","volume":"63","author":"Muriel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib313","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/TA.0b013e31802dd72a","article-title":"Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter study","volume":"62","author":"Karmy-Jones","year":"2007","journal-title":"J Trauma"},{"key":"10.1016\/j.jacc.2025.11.005_bib314","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jvsv.2022.11.002","article-title":"Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE): outcomes at 12 months","volume":"11","author":"Johnson","year":"2023","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jacc.2025.11.005_bib315","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jvir.2011.01.430","article-title":"Retrievability and device-related complications of the G2 filter: a retrospective study of 139 filter retrievals","volume":"22","author":"Zhu","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib316","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjmed.2011.05.025","article-title":"Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism","volume":"125","author":"Stein","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib317","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.amjcard.2017.11.007","article-title":"Usefulness of inferior vena cava filters in unstable patients with acute pulmonary embolism and patients who underwent pulmonary embolectomy","volume":"121","author":"Stein","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib318","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.amjmed.2013.11.003","article-title":"Vena cava filters in unstable elderly patients with acute pulmonary embolism","volume":"127","author":"Stein","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib319","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.amjmed.2018.09.023","article-title":"Inferior vena cava filters in patients with recurrent pulmonary embolism","volume":"132","author":"Stein","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib320","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial","volume":"313","author":"Mismetti","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib321","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1148\/radiol.12120372","article-title":"Complicated inferior vena cava filter retrievals: associated factors identified at preretrieval CT","volume":"266","author":"Dinglasan","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.jacc.2025.11.005_bib323","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jvir.2014.01.019","article-title":"Inferior vena cava filter retrieval: effectiveness and complications of routine and advanced techniques","volume":"25","author":"Al-Hakim","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib324","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jvir.2009.07.038","article-title":"Short- and long-term retrievability of the Celect vena cava filter: results from a multi-institutional registry","volume":"20","author":"Lyon","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib325","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jvsv.2018.11.007","article-title":"Trends in inferior vena cava filter placement and retrieval at a tertiary care institution","volume":"7","author":"Belkin","year":"2019","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jacc.2025.11.005_bib326","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00000441-200508000-00005","article-title":"Inferior vena caval filters: key considerations","volume":"330","author":"Failla","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jacc.2025.11.005_bib327","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00270-011-0151-9","article-title":"Perforation of the IVC: rule rather than exception after longer indwelling times for the Gunther Tulip and Celect retrievable filters","volume":"35","author":"Durack","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib328","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jvsv.2013.04.005","article-title":"Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism","volume":"1","author":"Morales","year":"2013","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jacc.2025.11.005_bib329","first-page":"866","article-title":"A systematic method for follow-up improves removal rates for retrievable inferior vena cava filters in a trauma patient population","volume":"69","author":"Irwin","year":"2010","journal-title":"J Trauma"},{"key":"10.1016\/j.jacc.2025.11.005_bib330","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11239-017-1513-1","article-title":"Implementation of an institutional protocol to improve inferior vena cava utilization and outcomes","volume":"44","author":"Rottenstreich","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib331","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jvsv.2015.11.002","article-title":"Improving the retrieval rate of inferior vena cava filters with a multidisciplinary team approach presented at the Twenty-sixth Annual Meeting of the American Venous Forum, New Orleans, LA, February 19-22, 2014","volume":"4","author":"Inagaki","year":"2016","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jacc.2025.11.005_bib332","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.amjcard.2018.09.040","article-title":"Usefulness of a computerized reminder system to improve inferior vena cava filter retrieval and complications","volume":"123","author":"Mikhael","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib333","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1358863X16676658","article-title":"A multidisciplinary quality improvement program increases the inferior vena cava filter retrieval rate","volume":"22","author":"Winters","year":"2017","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib334","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.surg.2009.06.022","article-title":"Institutional protocol improves retrievable inferior vena cava filter recovery rate","volume":"146","author":"Ko","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.jacc.2025.11.005_bib335","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.jvir.2010.09.003","article-title":"Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic","volume":"21","author":"Minocha","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib336","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1055\/s-2006-955466","article-title":"Risk stratification of acute pulmonary embolism","volume":"32","author":"Kucher","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib337","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jvir.2011.08.024","article-title":"Systematic review of the use of retrievable inferior vena cava filters","volume":"22","author":"Angel","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib338","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2023.10.026","article-title":"Contemporary management and outcomes of patients with high-risk pulmonary embolism","volume":"83","author":"Kobayashi","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib339","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/CIRCULATIONAHA.124.072364","article-title":"Large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the management of intermediate-risk pulmonary embolism: primary results of the PEERLESS randomized controlled trial","volume":"151","author":"Jaber","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib340","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/S0735-1097(03)00479-0","article-title":"Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry","volume":"41","author":"Torbicki","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib341","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/0885066618808193","article-title":"Right heart thrombi: patient outcomes by treatment modality and predictors of mortality: a pooled analysis","volume":"34","author":"Islam","year":"2019","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib342","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/eurheartj\/ehu218","article-title":"Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis","volume":"36","author":"Marti","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib343","first-page":"2163","article-title":"Phase 1 results: a cooperative study","volume":"214","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib344","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/153857447901300107","article-title":"Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison","volume":"13","author":"Dotter","year":"1979","journal-title":"Vasc Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib345","first-page":"Cd004437","article-title":"Thrombolytic therapy for pulmonary embolism","volume":"12","author":"Hao","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.11.005_bib346","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2014.5990","article-title":"Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis","volume":"311","author":"Chatterjee","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib347","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1097\/CCM.0000000000003288","article-title":"Half-dose versus full-dose alteplase for treatment of pulmonary embolism","volume":"46","author":"Kiser","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib348","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000006162","article-title":"Safety and Efficacy of Reduced-Dose Versus Full-Dose Alteplase for Acute Pulmonary Embolism: A Multicenter Observational Comparative Effectiveness Study","author":"Melamed","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib349","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/00033197231167062","article-title":"Reduced-dose thrombolysis in acute pulmonary embolism a systematic review","volume":"75","author":"Murguia","year":"2024","journal-title":"Angiology"},{"key":"10.1016\/j.jacc.2025.11.005_bib350","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0042-1758386","article-title":"Low-dose alteplase versus conventional anticoagulation to treat submassive pulmonary embolism in Hispanic patients","volume":"32","author":"Zientek","year":"2023","journal-title":"Int J Angiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib351","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.mayocp.2022.02.011","article-title":"Ultra-low-dose systemic tissue plasminogen activator in high-risk submassive pulmonary embolism","volume":"97","author":"Guru","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2025.11.005_bib352","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib353","article-title":"Incidence of mortality and complications in high-risk pulmonary embolism: a systematic review and meta-analysis","volume":"2","author":"Silver","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib354","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01062714","article-title":"Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial","volume":"2","author":"Jerjes-Sanchez","year":"1995","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib355","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.0954-6820.1978.tb14909.x","article-title":"A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism","volume":"203","author":"Ly","year":"1978","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jacc.2025.11.005_bib356","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jth.12521","article-title":"Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial","volume":"12","author":"Kline","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib357","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2016.12.039","article-title":"Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism","volume":"69","author":"Konstantinides","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib358","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jama.2022.22235","article-title":"Review of pulmonary embolism","volume":"329","author":"Porres-Aguilar","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib359","article-title":"Low dose peripheral systemic thrombolysis for treatment of intermediate-high risk acute pulmonary embolism: a case series","volume":"6","author":"Charif","year":"2022","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.jacc.2025.11.005_bib360","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib361","doi-asserted-by":"crossref","first-page":"280","DOI":"10.15441\/ceem.23.015","article-title":"Reduced-dose systemic fibrinolysis in massive pulmonary embolism: a pilot study","volume":"10","author":"Aykan","year":"2023","journal-title":"Clin Exp Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib362","first-page":"677","article-title":"Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism","volume":"29","author":"Surgit","year":"2023","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"10.1016\/j.jacc.2025.11.005_bib363","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1378\/chest.09-0765","article-title":"Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial","volume":"137","author":"Wang","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib364","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.amjcard.2012.09.027","article-title":"Moderate pulmonary embolism treated with thrombolysis (from the \"MOPETT\" Trial)","volume":"111","author":"Sharifi","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib365","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1055\/a-1653-4699","article-title":"Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial","volume":"122","author":"Sanchez","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib366","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1753944716630694","article-title":"Potential role of systemic thrombolysis in acute submassive intermediate risk pulmonary embolism: review and future perspectives","volume":"10","author":"Teleb","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2025.11.005_bib367","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjcard.2023.07.170","article-title":"Comparative outcomes of catheter-directed thrombolysis plus systemic anticoagulation versus systemic anticoagulation alone in the management of intermediate-risk pulmonary embolism in a systematic review and meta-analysis","volume":"205","author":"Balakrishna","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib368","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcin.2015.04.020","article-title":"A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study","volume":"8","author":"Piazza","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib369","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jcin.2018.04.008","article-title":"A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial","volume":"11","author":"Tapson","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib370","doi-asserted-by":"crossref","first-page":"E833","DOI":"10.1503\/cmaj.220960","article-title":"Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis","volume":"195","author":"Planer","year":"2023","journal-title":"CMAJ"},{"key":"10.1016\/j.jacc.2025.11.005_bib371","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.jcin.2022.09.011","article-title":"Pharmacomechanical catheter-directed thrombolysis with the bashir endovascular catheter for acute pulmonary embolism: the RESCUE study","volume":"15","author":"Bashir","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib372","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jvir.2009.08.002","article-title":"Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques","volume":"20","author":"Kuo","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib373","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"Kucher","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib374","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/jamacardio.2022.3591","article-title":"Catheter-directed thrombolysis vs anticoagulation in patients with acute intermediate-high-risk pulmonary embolism: the CANARY randomized clinical trial","volume":"7","author":"Sadeghipour","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib375","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib376","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jcin.2021.04.049","article-title":"Randomized Trial Comparing Standard Versus Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism: The SUNSET sPE Trial","volume":"14","author":"Avgerinos","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib377","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013448","article-title":"Prospective multicenter international registry of ultrasound-facilitated catheter-directed thrombolysis in intermediate-high and high-risk pulmonary embolism (KNOCOUT PE)","volume":"17","author":"Sterling","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib378","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1378\/chest.129.4.1043","article-title":"Management of unsuccessful thrombolysis in acute massive pulmonary embolism","volume":"129","author":"Meneveau","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib379","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11239-020-02255-9","article-title":"Rescue catheter-based therapies for the treatment of acute massive pulmonary embolism after unsuccessful systemic thrombolysis","volume":"51","author":"Gong","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib380","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCINTERVENTIONS.123.013406","article-title":"Outcomes in high-risk pulmonary embolism patients undergoing flowtriever mechanical thrombectomy or other contemporary therapies: results from the FLAME study","volume":"16","author":"Silver","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib381","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jcin.2018.12.022","article-title":"A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study","volume":"12","author":"Tu","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib382","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jcin.2020.09.053","article-title":"Indigo aspiration system for treatment of pulmonary embolism: results of the EXTRACT-PE trial","volume":"14","author":"Sista","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib383","first-page":"1345","article-title":"Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: interim results of the FLASH registry","volume":"99","author":"Toma","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.11.005_bib384","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4244\/EIJ-D-22-00732","article-title":"Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism","volume":"18","author":"Toma","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2025.11.005_bib385","first-page":"354","article-title":"Surgical embolectomy compared to thrombolysis in acute pulmonary embolism: morbidity and mortality","volume":"51","author":"Lehnert","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib386","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.hlc.2016.03.010","article-title":"Surgical pulmonary embolectomy: experience in a series of 37 consecutive cases","volume":"25","author":"Edelman","year":"2016","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2025.11.005_bib387","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jtcvs.2015.11.042","article-title":"Midterm benefits of surgical pulmonary embolectomy for acute pulmonary embolus on right ventricular function","volume":"152","author":"Keeling","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib388","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jtcvs.2017.10.139","article-title":"Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: a single-center experience","volume":"155","author":"Pasrija","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib389","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jacc.2020.06.065","article-title":"Survival and right ventricular function after surgical management of acute pulmonary embolism","volume":"76","author":"Goldberg","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14503\/THIJ-13-3877","article-title":"Acute surgical pulmonary embolectomy: a 9-year retrospective analysis","volume":"42","author":"Hartman","year":"2015","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.jacc.2025.11.005_bib391","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.athoracsur.2015.03.111","article-title":"Surgical embolectomy for acute massive and submassive pulmonary embolism in a series of 115 patients","volume":"100","author":"Neely","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib392","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.athoracsur.2016.05.004","article-title":"Outcomes after surgical pulmonary embolectomy for acute pulmonary embolus: a multi-institutional study","volume":"102","author":"Keeling","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib393","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.semtcvs.2021.06.011","article-title":"Comparison of surgical embolectomy and veno-arterial extracorporeal membrane oxygenation for massive pulmonary embolism","volume":"34","author":"Goldberg","year":"2022","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib394","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ijcard.2015.10.223","article-title":"Management of acute massive pulmonary embolism: is surgical embolectomy inferior to thrombolysis?","volume":"203","author":"Cho","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib395","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.hrtlng.2015.04.008","article-title":"Surgical embolectomy versus thrombolytic therapy in the management of acute massive pulmonary embolism: short and long-term prognosis","volume":"44","author":"Azari","year":"2015","journal-title":"Heart Lung"},{"key":"10.1016\/j.jacc.2025.11.005_bib396","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/ejcts\/ezs123","article-title":"Massive pulmonary embolism: surgical embolectomy versus thrombolytic therapy--should surgical indications be revisited?","volume":"43","author":"Aymard","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib397","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(11)60824-6","article-title":"Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial","volume":"378","author":"Aujesky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.11.005_bib398","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/rccm.201512-2494OC","article-title":"Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial","volume":"194","author":"den Exter","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib399","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1111\/j.1538-7836.2010.04041.x","article-title":"Safety of outpatient treatment in acute pulmonary embolism","volume":"8","author":"Erkens","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib400","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.rmed.2010.06.006","article-title":"Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism","volume":"104","author":"Klok","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib401","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.chest.2016.11.030","article-title":"Functional and exercise limitations after a first episode of pulmonary embolism: results of the ELOPE prospective cohort study","volume":"151","author":"Kahn","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib402","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/rth2.12123","article-title":"Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: results of the ELOPE study","volume":"2","author":"Ma","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib403","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1093\/eurheartj\/ehac206","article-title":"Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study","volume":"43","author":"Valerio","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib404","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1016\/S2352-3026(22)00215-0","article-title":"Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation","volume":"9","author":"Gwozdz","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jacc.2025.11.005_bib405","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/87551225231226431","article-title":"Assessment of population-based approach to direct oral anticoagulant management","volume":"40","author":"Ha","year":"2024","journal-title":"J Pharm Technol"},{"key":"10.1016\/j.jacc.2025.11.005_bib406","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12696","article-title":"Optimization of DOAC management services in a centralized anticoagulation clinic","volume":"6","author":"Sylvester","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib407","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2023.11.013","article-title":"Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: a mixed-methods systematic review","volume":"233","author":"Ingemann-Molden","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib408","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105978","article-title":"The lived experience with pulmonary embolism: a qualitative study using focus groups","volume":"167","author":"Kirchberger","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib409","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1538-7836.2009.03726.x","article-title":"Quality of life after pulmonary embolism: validation of the PEmb-QoL Questionnaire","volume":"8","author":"Klok","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib410","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/rth2.12484","article-title":"The psychological impact of pulmonary embolism: a mixed-methods study","volume":"5","author":"Tran","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib411","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00846-2023","article-title":"Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry","volume":"63","author":"Durrington","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib412","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2024.01.008","article-title":"Performance-based outcome measures for assessing physical capacity in patients with pulmonary embolism: a scoping review","volume":"235","author":"Caspersen","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib413","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa1506623","article-title":"Screening for occult cancer in unprovoked venous thromboembolism","volume":"373","author":"Carrier","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib414","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1470-2045(15)00480-5","article-title":"Limited screening with versus without (18)F-fluorodeoxyglucose PET\/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial","volume":"17","author":"Robin","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jacc.2025.11.005_bib415","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1538-7836.2010.04101.x","article-title":"Is extensive screening for cancer in idiopathic venous thromboembolism warranted?","volume":"9","author":"Van Doormaal","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib416","doi-asserted-by":"crossref","first-page":"410","DOI":"10.7326\/M17-0868","article-title":"Screening for occult cancer in patients with unprovoked venous thromboembolism: a systematic review and meta-analysis of individual patient data","volume":"167","author":"van Es","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib417","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib418","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/bjh.12575","article-title":"Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry","volume":"163","author":"Weingarz","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2025.11.005_bib419","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jth.14226","article-title":"Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism","volume":"16","author":"Huisman","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib420","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1160\/TH16-11-0874","article-title":"Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin","volume":"117","author":"Brekelmans","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib421","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.thromres.2015.07.030","article-title":"Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists","volume":"136","author":"De Crem","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib422","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2025.11.005_bib423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.001","article-title":"Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism","volume":"93-95","author":"Godin","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jacc.2025.11.005_bib424","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020952019","article-title":"Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolus","volume":"10","author":"Lachant","year":"2020","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacc.2025.11.005_bib425","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12758","article-title":"Anticoagulation stewardship: descriptive analysis of a novel approach to appropriate anticoagulant prescription","volume":"6","author":"Koolian","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib426","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12803","article-title":"Implementing evidence-based anticoagulant prescribing: user-centered design findings and recommendations","volume":"6","author":"Seagull","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib427","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jtha.2022.12.006","article-title":"Venous thromboembolism and risk of depression: a population-based cohort study","volume":"21","author":"J\u00f8rgensen","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib428","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2022.12.013","article-title":"Depression and anxiety up to two years after acute pulmonary embolism: prevalence and predictors","volume":"222","author":"Fischer","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib429","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/1359105314540965","article-title":"Predicting post-traumatic stress and health anxiety following a venous thrombotic embolism","volume":"21","author":"Bennett","year":"2016","journal-title":"J Health Psychol"},{"key":"10.1016\/j.jacc.2025.11.005_bib430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2022.11.016","article-title":"Impact of hospital-based multidisciplinary anticoagulation stewardship programs","volume":"54","author":"Porres-Aguilar","year":"2023","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib431","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ccm.2018.04.019","article-title":"Pulmonary embolism response team: inpatient structure, outpatient follow-up, and is it the current standard of care?","volume":"39","author":"Rosovsky","year":"2018","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib432","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.blre.2014.07.003","article-title":"The post-PE syndrome: a new concept for chronic complications of pulmonary embolism","volume":"28","author":"Klok","year":"2014","journal-title":"Blood Rev"},{"key":"10.1016\/j.jacc.2025.11.005_bib433","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.rmed.2014.08.002","article-title":"Impaired 6-min walk test, heart rate recovery and cardiac function post pulmonary embolism in long-term survivors","volume":"108","author":"Chow","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib434","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102366","article-title":"Physical activity following pulmonary embolism and clinical correlates in selected patients: a cross-sectional study","volume":"8","author":"Haukeland-Parker","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib435","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7326\/0003-4819-149-5-200809020-00007","article-title":"Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?","volume":"149","author":"Carrier","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib436","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archinternmed.2010.367","article-title":"Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review","volume":"170","author":"Iorio","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib437","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1538-7836.2008.03005.x","article-title":"The psychological impact of testing for thrombophilia: a systematic review","volume":"6","author":"Cohn","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib438","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.thromres.2011.05.024","article-title":"Psychological impact of thrombophilia testing in asymptomatic family members","volume":"128","author":"Louzada","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib439","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1055\/a-2284-4285","article-title":"Thrombophilia testing: from genetic predisposition to discrimination","volume":"8","author":"Verstraete","year":"2024","journal-title":"TH Open"},{"key":"10.1016\/j.jacc.2025.11.005_bib440","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jacc.2025.11.005_bib441","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0043-1764468","article-title":"Laboratory evaluation of antithrombin, protein C, and protein S","volume":"49","author":"Marlar","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib442","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1016\/S2352-3026(20)30327-6","article-title":"Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort study","volume":"7","author":"Beyer-Westendorf","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jacc.2025.11.005_bib443","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00428-010-0982-9","article-title":"Warfarin embryopathy: fetal manifestations","volume":"457","author":"Wainwright","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jacc.2025.11.005_bib444","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(22)02128-6","article-title":"Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial","volume":"400","author":"Bistervels","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.11.005_bib445","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40264-021-01072-0","article-title":"Risk of severe abnormal uterine bleeding associated with rivaroxaban compared with apixaban, dabigatran and warfarin","volume":"44","author":"Eworuke","year":"2021","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacc.2025.11.005_bib446","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/1471-0528.15388","article-title":"Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study","volume":"125","author":"Scheres","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.jacc.2025.11.005_bib447","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/01.AOG.0000428646.67925.9a","article-title":"557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.11.005_bib448","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.43730","article-title":"Association of hormonal contraceptive use with adverse health outcomes: an umbrella review of meta-analyses of randomized clinical trials and cohort studies","volume":"5","author":"Brabaharan","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.11.005_bib449","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jtha.2024.03.014","article-title":"Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women","volume":"22","author":"Verlaan","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib450","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2008.06.020","article-title":"A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both","volume":"137","author":"Aissaoui","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib451","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11739-021-02762-4","article-title":"Pulmonary embolism after a long-haul flight","volume":"17","author":"Saleh","year":"2022","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib452","article-title":"Compression stockings for preventing deep vein thrombosis in airline passengers","volume":"4","author":"Clarke","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.11.005_bib453","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.10779","article-title":"Comparison of 4 acute pulmonary embolism mortality risk scores in patients evaluated by pulmonary embolism response teams","volume":"3","author":"Barnes","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.11.005_bib454","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.10516","article-title":"The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients","volume":"92","author":"Prandoni","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jacc.2025.11.005_bib455","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/jth.13524","article-title":"The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study","volume":"14","author":"Kyrle","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib456","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d3036","article-title":"Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials","volume":"342","author":"Boutitie","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.11.005_bib457","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bjh.16275","volume":"188","author":"Bradbury","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2025.11.005_bib458","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archinternmed.2010.367","article-title":"Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review","volume":"170","author":"Iorio","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib459","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/bloodadvances.2024015371","article-title":"Duration of primary\/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jacc.2025.11.005_bib460","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/S2352-3026(16)00023-5","article-title":"Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study","volume":"3","author":"Raskob","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jacc.2025.11.005_bib461","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1160\/TH17-03-0210","article-title":"Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism","volume":"117","author":"Coleman","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib462","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7326\/M21-1094","article-title":"Long-Term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis","volume":"174","author":"Khan","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib463","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/jth.12923","article-title":"Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study","volume":"13","author":"Francis","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib464","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2017.07.004","article-title":"Tinzaparin in cancer associated thrombosis beyond 6months: TiCAT study","volume":"157","author":"Jara-Palomares","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib465","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/jth.14561","article-title":"Extended treatment with edoxaban in cancer patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE Cancer study","volume":"17","author":"Di Nisio","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib466","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/jth.14752","article-title":"Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m)","volume":"18","author":"Marshall","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib467","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/jth.15666","article-title":"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up","volume":"20","author":"Larsen","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib468","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jtha.2024.03.011","article-title":"Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial","volume":"22","author":"McBane","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib469","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism","volume":"340","author":"Kearon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib470","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.2015.7046","article-title":"Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS-PE randomized clinical trial","volume":"314","author":"Couturaud","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib471","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/heartjnl-2018-313617","article-title":"Extended treatment of venous thromboembolism: a systematic review and network meta-analysis","volume":"105","author":"Wang","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2025.11.005_bib472","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(24)02842-3","article-title":"Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial","volume":"405","author":"Couturaud","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.11.005_bib473","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa2416112","article-title":"Extended reduced-dose apixaban for cancer-associated venous thromboembolism","volume":"392","author":"Mahe","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib474","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib475","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib476","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03002-2021","article-title":"Risk stratification for predicting recurrent venous thromboembolism after discontinuation of anticoagulation: a post hoc analysis of a French prospective multicentre study","volume":"60","author":"Le Mao","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib477","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0038-1661387","article-title":"Risk of Recurrent Venous Thromboembolism in Autoimmune Diseases: A Systematic Review of the Literature","volume":"45","author":"Borjas-Howard","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib478","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","article-title":"Extended use of dabigatran, warfarin, or placebo in venous thromboembolism","volume":"368","author":"Schulman","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib479","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib480","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib481","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib482","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2025.11.005_bib483","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib484","article-title":"Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer","volume":"6","author":"Kahale","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.11.005_bib485","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2023.7843","article-title":"Direct oral anticoagulants vs low-molecular-weight heparin and recurrent VTE in patients with cancer: a randomized clinical trial","volume":"329","author":"Schrag","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.11.005_bib486","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chest.2021.09.037","article-title":"Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial","volume":"161","author":"Planquette","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib487","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib488","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jth.14662","article-title":"Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial","volume":"18","author":"McBane","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib489","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024358","article-title":"Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database","volume":"11","author":"Lutsey","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.11.005_bib490","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurheartj\/ehac776","article-title":"Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score","volume":"44","author":"De Winter","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib491","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib492","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood-2017-03-742304","article-title":"How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy","volume":"129","author":"Schulman","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2025.11.005_bib493","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jtha.2023.01.030","article-title":"Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data","volume":"21","author":"Robin","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib494","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1365-2141.2007.06679.x","article-title":"Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism","volume":"138","author":"Lobo","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2025.11.005_bib495","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2009.03326.x","article-title":"Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients","volume":"7","author":"Carrier","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib496","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"Van Es","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2025.11.005_bib497","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.thromres.2022.02.001","article-title":"Use of D-dimer for the exclusion of new pulmonary embolism in anticoagulated patients: a multicenter retrospective study","volume":"212","author":"Beaudoin","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib498","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11239-018-1690-6","article-title":"Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events","volume":"46","author":"Chopard","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib499","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1160\/TH16-07-0494","article-title":"Real-life treatment of venous thromboembolism with direct oral anticoagulants: the influence of recommended dosing and regimens","volume":"117","author":"Trujillo-Santos","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib500","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/pharmaceutics14061120","article-title":"Drug-drug interactions of direct oral anticoagulants (DOACs): from pharmacological to clinical practice","volume":"14","author":"Ferri","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jacc.2025.11.005_bib501","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/0091270006286904","article-title":"Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects","volume":"46","author":"Kubitza","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2025.11.005_bib502","first-page":"1","article-title":"Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)","author":"Hakeam","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1024\/0301-1526\/a001089","article-title":"Diagnostics and therapy of venous thrombosis and pulmonary embolism. The revised AWMF S2k guideline","volume":"52","author":"Linnemann","year":"2023","journal-title":"Vasa"},{"key":"10.1016\/j.jacc.2025.11.005_bib504","doi-asserted-by":"crossref","first-page":"510","DOI":"10.5811\/westjem.2018.1.35586","article-title":"Acute pulmonary embolism in emergency department patients despite therapeutic anticoagulation","volume":"19","author":"Liu","year":"2018","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib505","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaccao.2023.10.009","article-title":"Comparing anticoagulation strategies for venous thromboembolism associated with active cancer: a systematic review and meta-analysis","volume":"6","author":"Fujisaki","year":"2024","journal-title":"JACC CardioOncology"},{"key":"10.1016\/j.jacc.2025.11.005_bib506","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11239-020-02180-x","article-title":"Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE","volume":"50","author":"Weitz","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2025.11.005_bib507","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1093\/eurheartj\/ehac206","article-title":"Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study","volume":"43","author":"Valerio","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.11.005_bib508","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/thoraxjnl-2020-216324","article-title":"Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study","volume":"76","author":"Boon","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jacc.2025.11.005_bib509","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00846-2023","article-title":"Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry","volume":"63","author":"Durrington","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib510","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000358565","article-title":"Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography","volume":"87","author":"Held","year":"2014","journal-title":"Respiration"},{"key":"10.1016\/j.jacc.2025.11.005_bib511","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2016.12.039","article-title":"Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism","volume":"69","author":"Konstantinides","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib512","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jtcvs.2016.05.058","article-title":"Hemodynamic and ventilatory responses during exercise in chronic thromboembolic disease","volume":"152","author":"van Kan","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib513","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01787-2018","article-title":"Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension","volume":"53","author":"Swietlik","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib514","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MNM.0b013e328344dfd5","article-title":"Tomographic ventilation\/perfusion lung scintigraphy in the monitoring of the effect of treatment in pulmonary embolism: serial follow-up over a 6-month period","volume":"32","author":"Begic","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jacc.2025.11.005_bib515","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/rth2.12123","article-title":"Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: results of the ELOPE study","volume":"2","author":"Ma","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib516","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNM.0b013e32835085d9","article-title":"Diagnosis of chronic thromboembolic pulmonary hypertension: comparison of ventilation\/perfusion scanning and multidetector computed tomography pulmonary angiography with pulmonary angiography","volume":"33","author":"He","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jacc.2025.11.005_bib517","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/rth2.12123","article-title":"Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: results of the ELOPE study","volume":"2","author":"Ma","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib518","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1160\/TH14-10-0842","article-title":"Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism","volume":"114","author":"den Exter","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib519","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2023.10.003","article-title":"Anticoagulation in chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis","volume":"231","author":"Ishisaka","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2025.11.005_bib520","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.chest.2023.04.042","article-title":"The effects of exercise training in patients with persistent dyspnea following pulmonary embolism: a randomized controlled trial","volume":"164","author":"Jervan","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib521","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0064","article-title":"Effect of a physiotherapist-guided home-based exercise intervention on physical capacity and patient-reported outcomes among patients with acute pulmonary embolism: a randomized clinical trial","volume":"3","author":"Rolving","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.11.005_bib522","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/jth.12989","article-title":"The safety and efficacy of early-initiation exercise training after acute venous thromboembolism: a randomized clinical trial","volume":"13","author":"Lakoski","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib523","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.115.016522","article-title":"Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry","volume":"133","author":"Delcroix","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.11.005_bib524","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.athoracsur.2021.11.005","article-title":"Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: an STS Database analysis","volume":"114","author":"Bergquist","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib525","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02095-2018","article-title":"French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"53","author":"Brenot","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib526","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.chest.2016.11.030","article-title":"Functional and exercise limitations after a first episode of pulmonary embolism: results of the ELOPE prospective cohort study","volume":"151","author":"Kahn","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib527","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00059-2023","article-title":"Cardiopulmonary exercise testing during follow-up after acute pulmonary embolism","volume":"61","author":"Farmakis","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib528","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01792-2016","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature","volume":"49","author":"Ende-Verhaar","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib529","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107177","article-title":"Frequency and characterization of CTEPH and CTEPD according to the mPAP threshold >20 mm Hg: retrospective analysis from data of a prospective PE aftercare program","volume":"210","author":"Held","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib530","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2967\/jnumed.106.039438","article-title":"Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension","volume":"48","author":"Tunariu","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib531","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2967\/jnumed.120.243188","article-title":"A prospective, comparative study of ventilation-perfusion planar imaging and ventilation-perfusion spect for chronic thromboembolic pulmonary hypertension","volume":"61","author":"Wang","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib532","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/RLU.0000000000005142","article-title":"Diagnostic performance of perfusion-only SPECT\/CT for chronic thromboembolic pulmonary hypertension in comparison with ventilation-perfusion planar, SPECT, and SPECT\/CT imaging","volume":"49","author":"Sung","year":"2024","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib533","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.chest.2019.10.047","article-title":"Dyspnea postpulmonary embolism from physiological dead space proportion and stroke volume defects during exercise","volume":"157","author":"Fernandes","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib534","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00421-012-2407-8","article-title":"Noninvasive assessment of normality of VD\/VT in clinical cardiopulmonary exercise testing utilizing incremental cycle ergometry","volume":"113","author":"Roman","year":"2013","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.jacc.2025.11.005_bib535","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/jth.14477","article-title":"Risk of recurrent venous thromboembolism after acute pulmonary embolism: role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis","volume":"17","author":"Becattini","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.11.005_bib536","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1513\/AnnalsATS.201901-061PS","article-title":"The post-pulmonary embolism syndrome: real or ruse?","volume":"16","author":"Pugliese","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jacc.2025.11.005_bib537","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.chest.2023.04.042","article-title":"The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial","volume":"164","author":"Jervan","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.11.005_bib538","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00589-2018","article-title":"The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension","volume":"52","author":"Quadery","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib539","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S2213-2600(22)00214-4","article-title":"Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study","volume":"10","author":"Ja\u00efs","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib540","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-2600(22)00171-0","article-title":"Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial","volume":"10","author":"Kawakami","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacc.2025.11.005_bib541","doi-asserted-by":"crossref","first-page":"128","DOI":"10.21037\/acs-2021-pte-17","article-title":"Pulmonary thromboendarterectomy-the Royal Papworth experience","volume":"11","author":"Jenkins","year":"2022","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2025.11.005_bib542","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00458-2018","article-title":"Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease","volume":"52","author":"Guth","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.11.005_bib543","article-title":"Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease","volume":"8","author":"Wiedenroth","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacc.2025.11.005_bib544","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12409","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertension","volume":"14","author":"Kiko","year":"2024","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacc.2025.11.005_bib545","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.healun.2023.04.016","article-title":"Natural history of chronic thromboembolic pulmonary disease with no or mild pulmonary hypertension","volume":"42","author":"Reddy","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2025.11.005_bib546","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2026.06.033","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000}}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725101617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725101617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:00:48Z","timestamp":1785340848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725101617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":544,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0735109725101617"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.11.005","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2026 AHA\/ACC\/ACCP\/ACEP\/CHEST\/SCAI\/SHM\/SIR\/SVM\/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}